Bulk metallic glass nanomoulding for glucose sensors
用于葡萄糖传感器的块状金属玻璃纳米成型
基本信息
- 批准号:10153766
- 负责人:
- 金额:$ 41.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesivesAdoptedAlloysArchitectureBiocompatible MaterialsBiologicalBiological AssayBlood GlucoseBlood VesselsCellsCellular AssayChemistryClinicalCollagenCorrosionDiabetes MellitusDiffusionDiseaseEdemaElectrodesEncapsulatedEngineeringEvaluationFibroblastsForeign BodiesForeign-Body Giant CellsGenerationsGeometryGlassGlucoseHealthImplantInfiltrationInflammationInflammatoryInflammatory ResponseInsulinIntercellular FluidLibrariesLongevityMacrophage ActivationMediatingMiniaturizationModificationMonitorMorphologyPatient MonitoringPatientsPatternPlatinumPolymersPorosityPropertyProteinsReactionResistanceSeriesSleepStructureSurfaceSystemTestingTissuesVascularizationZirconiumbasebiomaterial compatibilitycapsulecompliance behaviorcytokinedesigndiabetes managementdiabetic ratexperienceexperimental studyglucose monitorglucose sensorhigh throughput screeningimplantable deviceimprovedimproved functioningin vivolearning materialsmacrophagemetallicitynanopatternnanorodnanoscaleneovascularizationnovelrelease factorresponsescreeningsensortissue injuryvirtual
项目摘要
Project Summary
Diabetes mellitus (DM) remains an incurable disease that is poised to increase in the next two decades.
Management of DM is mediated primarily by insulin therapy, which depends on patients monitoring their blood
glucose levels. However, due to lack of patient compliance, inaccuracies of strip sensors, and inability to test
for long periods such as during sleep, patients experience hyper- and hypo-glycemic episodes. Continuous
glucose monitoring from indwelling sensors holds the promise of a closed loop insulin delivery system. Despite
significant improvements in sensor design and overall accuracy, obstacles towards the long-term successful
application of such sensors remain. These include the need for miniaturization to minimize tissue injury
without a loss in sensitivity/ accuracy, biofouling, and the foreign body response (FBR). Approaches to improve
sensor function include delivery of tissue modifiers to modulate inflammatory responses. However, to date the
longevity of indwelling sensors is limited to 3-14 days and the inclusion of biologics to sensors complicates
manufacturing and creates additional regulatory burdens. Therefore, a biomaterial-based approach to
modulate the FBR and improve sensor function represents an attractive solution. In this application, we
propose the generation of a novel glucose sensor coating based on bulk metallic glass (BMG). BMGs are
metallic alloys with an amorphous atomic structure that combine high corrosion resistance and polymer-like
processability. Specifically, we propose to systematically evaluate Platinum or Zirconium based BMG
chemistries and geometries to develop a bio-protective surface for an indwelling glucose sensor. Accordingly,
the specific aims of this application are: 1) to screen BMG libraries for desirable material properties and
biological responses; 2) to identify BMG topographical features capable of favorably modulating in vivo
responses; and 3) to integrate BMG topographical features to enhance sensor function. Such bio-protective
surfaces could be used to shield virtually any biomedical implant from adverse biological reactions, thereby
improving implant function and lifespan.
项目摘要
糖尿病(DM)仍然是一种无法治愈的疾病,在未来二十年中有望增加。
DM的管理主要是由胰岛素治疗介导的,胰岛素治疗取决于患者监测血液
葡萄糖水平。但是,由于缺乏患者依从性,脱衣传感器不准确以及无法测试
在睡眠期间,患者长期存在高血糖发作。连续的
来自留置传感器的葡萄糖监测具有封闭环胰岛素输送系统的承诺。尽管
传感器设计和整体准确性的显着改善,长期成功的障碍
保留此类传感器的应用。这些包括需要小型化以最大程度地减少组织损伤
敏感性/准确性,生物污染和异物反应(FBR)而不会丧失。改进的方法
传感器功能包括传递组织修饰符以调节炎症反应。但是,迄今为止
留置传感器的寿命限制为3-14天,并且将生物制剂纳入传感器很复杂
制造并产生其他监管负担。因此,一种基于生物材料的方法
调节FBR并改善传感器功能代表一个有吸引力的解决方案。在此应用程序中,我们
提出基于块状金属玻璃(BMG)的新型葡萄糖传感器涂料的产生。 BMG是
具有无定形原子结构的金属合金,结合了高腐蚀性和聚合物样
加工性。具体而言,我们建议系统地评估铂或锆基BMG
化学和几何形状为留置葡萄糖传感器开发生物保护表面。因此,
该应用程序的具体目的是:1)筛选BMG库的理想材料属性,并
生物反应; 2)识别BMG地形特征,能够在体内调节
回应; 3)集成BMG地形特征以增强传感器功能。这样的生物保护
表面可用于将几乎任何生物医学植入物免于不良生物反应,从而屏蔽任何生物医学植入物
改善植入物功能和寿命。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity.
- DOI:10.1088/1748-605x/ac5574
- 发表时间:2022-03-04
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THEMIS R KYRIAKIDES其他文献
THEMIS R KYRIAKIDES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THEMIS R KYRIAKIDES', 18)}}的其他基金
ECM biomaterials for diabetic foot ulcers
用于糖尿病足溃疡的 ECM 生物材料
- 批准号:
10432878 - 财政年份:2022
- 资助金额:
$ 41.78万 - 项目类别:
ECM biomaterials for diabetic foot ulcers
用于糖尿病足溃疡的 ECM 生物材料
- 批准号:
10610940 - 财政年份:2022
- 资助金额:
$ 41.78万 - 项目类别:
THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS
新型 AIP1 同种型在病理性淋巴管生成中的作用
- 批准号:
10218254 - 财政年份:2013
- 资助金额:
$ 41.78万 - 项目类别:
THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS
新型 AIP1 同种型在病理性淋巴管生成中的作用
- 批准号:
10018087 - 财政年份:2013
- 资助金额:
$ 41.78万 - 项目类别:
NAVBO's Workshop on Vascular Matrix Biology and Bioengineering
NAVBO 血管基质生物学和生物工程研讨会
- 批准号:
8130114 - 财政年份:2011
- 资助金额:
$ 41.78万 - 项目类别:
MCP-1 and attenuation of the foreign body response
MCP-1和异物反应的衰减
- 批准号:
7027107 - 财政年份:2005
- 资助金额:
$ 41.78万 - 项目类别:
MCP-1 and attenuation of the foreign body response
MCP-1和异物反应的衰减
- 批准号:
8258805 - 财政年份:2005
- 资助金额:
$ 41.78万 - 项目类别:
MCP-1 and attenuation of the foreign body response
MCP-1和异物反应的衰减
- 批准号:
7628682 - 财政年份:2005
- 资助金额:
$ 41.78万 - 项目类别:
MCP-1 and attenuation of the foreign body response
MCP-1和异物反应的衰减
- 批准号:
6924404 - 财政年份:2005
- 资助金额:
$ 41.78万 - 项目类别:
MCP-1 and attenuation of the foreign body response
MCP-1和异物反应的衰减
- 批准号:
8459007 - 财政年份:2005
- 资助金额:
$ 41.78万 - 项目类别:
相似国自然基金
页岩油气开采用溶解可控高强Mg-RE合金性能与制备一体化调控机理
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
页岩油气开采用溶解可控高强Mg-RE合金性能与制备一体化调控机理
- 批准号:52171097
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
采用3D打印多层中空壳型水冷实现定向凝固的新工艺研究
- 批准号:51875308
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
采用小孔和孔内等离子体逐层截面直接观测技术的激光深熔焊接铝合金小孔形成机理研究
- 批准号:51875189
- 批准年份:2018
- 资助金额:65.0 万元
- 项目类别:面上项目
采用氮化物(合金)向钢中增氮的作用机理研究
- 批准号:51364031
- 批准年份:2013
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Radionuclide Production and Radiochemistry Core Description Core
放射性核素生产和放射化学核心描述核心
- 批准号:
10416050 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
Radionuclide Production and Radiochemistry Core Description Core
放射性核素生产和放射化学核心描述核心
- 批准号:
10263251 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
Radionuclide Production and Radiochemistry Core Description Core
放射性核素生产和放射化学核心描述核心
- 批准号:
10672957 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
Radionuclide Production and Radiochemistry Core Description Core
放射性核素生产和放射化学核心描述核心
- 批准号:
10024891 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
The Innovative Cut-to-Coat Process for Low Cost Manufacturing Digital Rx Lenses
用于低成本制造数字接收镜头的创新切割涂层工艺
- 批准号:
8123713 - 财政年份:2011
- 资助金额:
$ 41.78万 - 项目类别: